| Literature DB >> 20727744 |
M Walter1, K Isensee, T Kottke, X Ligneau, J-C Camelin, J-C Schwartz, H Stark.
Abstract
With a small series of compounds we demonstrated the variability in the core region of the human histamine H(3) receptor (hH(3)R) antagonist structural blueprint by introducing polar azole groups (oxazole, oxadiazole, thiazole and triazole). Additional variations achieved by coupling different residues to the heterocyclic core structure led to further optimisation of in vitro receptor binding of the novel azole derivatives.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20727744 DOI: 10.1016/j.bmcl.2010.07.109
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823